Home » ImmunoVaccine Scales Up VacciMax to Commercial Scale
ImmunoVaccine Scales Up VacciMax to Commercial Scale
ImmunoVaccine Technologies announced that it has successfully scaled-up the manufacturing process for its vaccine platform, Vaccimax. This work validates the suitability of the platform for commercial applications in therapeutic cancer and infectious disease indications.
Yahoo! Finance
Yahoo! Finance
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May